Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

PK Study of Dapagliflozin in Pediatric Subjects With T2DM

This study has been completed.
Information provided by (Responsible Party):
Bristol-Myers Squibb Identifier:
First received: January 31, 2012
Last updated: February 6, 2015
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)